Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Solid Tumor 3Lung Neoplasms 3Breast Neoplasms 3Glioma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Oncologic Diseases 1Neurotoxicity Syndromes 1Melanoma 1Liver Cirrhosis 1Glioblastoma 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Blood Specimen Collection 14Nivolumab 13Ipilimumab 12pembrolizumab 11trametinib 9Surveys and Questionnaires 9Gene Expression Profiling 9dabrafenib 8Biopsy 6Specimen Handling 5Immunotherapy 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 4encorafenib 3binimetinib 3atezolizumab 3Restraint, Physical 3Quality of Life 3Polymerase Chain Reaction 3Introns 3Flow Cytometry 3Drug Therapy 3Data Collection 3tremelimumab 2pimonidazole 2cobimetinib 2aldesleukin 2Watchful Waiting 2Vemurafenib 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Melanoma × Fluorodeoxyglucose F18 × Clear all
NCT05645484 2023-02-21

The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Unknown
100 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡